<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id><journal-title-group><journal-title>Molecular Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">1359-4184</issn><issn pub-type="epub">1476-5578</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27528461</article-id><article-id pub-id-type="pmc">5030463</article-id><article-id pub-id-type="pii">mp2016140</article-id><article-id pub-id-type="doi">10.1038/mp.2016.140</article-id><article-categories><subj-group subj-group-type="heading"><subject>Corrigendum</subject></subj-group></article-categories><title-group><article-title>A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients</article-title><alt-title alt-title-type="running">Corrigendum</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fava</surname><given-names>M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Johe</surname><given-names>K</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ereshefsky</surname><given-names>L</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gertsik</surname><given-names>L G</given-names></name></contrib><contrib contrib-type="author"><name><surname>English</surname><given-names>B A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bilello</surname><given-names>J A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Thurmond</surname><given-names>L M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Johnstone</surname><given-names>J</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dickerson</surname><given-names>B C</given-names></name></contrib><contrib contrib-type="author"><name><surname>Makris</surname><given-names>N</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hoeppner</surname><given-names>B B</given-names></name></contrib><contrib contrib-type="author"><name><surname>Flynn</surname><given-names>M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mischoulon</surname><given-names>D</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kinrys</surname><given-names>G</given-names></name></contrib><contrib contrib-type="author"><name><surname>Freeman</surname><given-names>M P</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><month>10</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>16</day><month>08</month><year>2016</year></pub-date><volume>21</volume><issue>10</issue><fpage>1483</fpage><lpage>1484</lpage><permissions><copyright-statement>Copyright © 2016 The Author(s)</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license></permissions><related-article id="d34e39" related-article-type="corrected-article" ext-link-type="doi" xlink:href="10.1038/mp.2015.178"></related-article></article-meta></front><body><p><bold><offsets xml_i="4093" xml_f="4107" txt_i="7" txt_f="21">Correction to:</offsets></bold><offsets xml_i="4114" xml_f="4115" txt_i="21" txt_f="22">
</offsets><italic><offsets xml_i="4123" xml_f="4143" txt_i="22" txt_f="42">Molecular Psychiatry</offsets></italic><offsets xml_i="4152" xml_f="4202" txt_i="42" txt_f="92"> advance online publication, 8 December 2015; doi:</offsets><ext-link ext-link-type="uri" xlink:href="/doifinder/10.1038/mp.2015.178"><offsets xml_i="4276" xml_f="4295" txt_i="92" txt_f="111">10.1038/mp.2015.178</offsets></ext-link></p><p><offsets xml_i="4313" xml_f="4375" txt_i="112" txt_f="174">Following publication of this paper, the authors noticed that </offsets><xref ref-type="fig" rid="fig5"><offsets xml_i="4407" xml_f="4423" txt_i="174" txt_f="190">Figures 5a and b</offsets></xref><offsets xml_i="4430" xml_f="4490" txt_i="190" txt_f="250"> contained the same image. In addition, there was a typo in </offsets><xref rid="tbl3" ref-type="table"><offsets xml_i="4524" xml_f="4531" txt_i="250" txt_f="257">Table 3</offsets></xref><offsets xml_i="4538" xml_f="4589" txt_i="257" txt_f="308"> at #703. The correct figure and table appear here.</offsets></p></body><floats-group><fig id="fig5"><label>Figure 5</label><caption><p>(<bold>a</bold>–<bold>d</bold>) Efficacy outcomes in means over time.</p></caption><graphic xlink:href="mp2016140f5"></graphic></fig><table-wrap id="tbl3"><label>Table 3</label><caption><title>Baseline biomarker levels and the probability of response to NSI-189 at day 28</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"></col><col align="left"></col><col align="char" char="."></col></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"><italic>Patient. ID</italic></th><th align="left" valign="top" charoff="50"><italic>Designation</italic></th><th align="center" valign="top" char="." charoff="50"><italic>Probablilty</italic></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">501</td><td align="left" valign="top" charoff="50">PR</td><td align="char" valign="top" char="." charoff="50">1.000</td></tr><tr><td align="left" valign="top" charoff="50">502</td><td align="left" valign="top" charoff="50">R</td><td align="char" valign="top" char="." charoff="50">1.000</td></tr><tr><td align="left" valign="top" charoff="50">504</td><td align="left" valign="top" charoff="50">R</td><td align="char" valign="top" char="." charoff="50">1.000</td></tr><tr><td align="left" valign="top" charoff="50">505</td><td align="left" valign="top" charoff="50">R</td><td align="char" valign="top" char="." charoff="50">1.000</td></tr><tr><td align="left" valign="top" charoff="50">506</td><td align="left" valign="top" charoff="50">R</td><td align="char" valign="top" char="." charoff="50">1.000</td></tr><tr><td align="left" valign="top" charoff="50">508</td><td align="left" valign="top" charoff="50">NR</td><td align="char" valign="top" char="." charoff="50">0.032</td></tr><tr><td align="left" valign="top" charoff="50">602</td><td align="left" valign="top" charoff="50">R</td><td align="char" valign="top" char="." charoff="50">1.000</td></tr><tr><td align="left" valign="top" charoff="50">603</td><td align="left" valign="top" charoff="50">R</td><td align="char" valign="top" char="." charoff="50">0.961</td></tr><tr><td align="left" valign="top" charoff="50">604</td><td align="left" valign="top" charoff="50">PR</td><td align="char" valign="top" char="." charoff="50">1.000</td></tr><tr><td align="left" valign="top" charoff="50">606</td><td align="left" valign="top" charoff="50">PR</td><td align="char" valign="top" char="." charoff="50">0.998</td></tr><tr><td align="left" valign="top" charoff="50">608*</td><td align="left" valign="top" charoff="50">PR*</td><td align="char" valign="top" char="." charoff="50">0.000*</td></tr><tr><td align="left" valign="top" charoff="50">627</td><td align="left" valign="top" charoff="50">R</td><td align="char" valign="top" char="." charoff="50">0.980</td></tr><tr><td align="left" valign="top" charoff="50">701</td><td align="left" valign="top" charoff="50">R</td><td align="char" valign="top" char="." charoff="50">1.000</td></tr><tr><td align="left" valign="top" charoff="50">702</td><td align="left" valign="top" charoff="50">R</td><td align="char" valign="top" char="." charoff="50">0.987</td></tr><tr><td align="left" valign="top" charoff="50">703</td><td align="left" valign="top" charoff="50">NR</td><td align="char" valign="top" char="." charoff="50">0.000</td></tr><tr><td align="left" valign="top" charoff="50">705</td><td align="left" valign="top" charoff="50">NR</td><td align="char" valign="top" char="." charoff="50">0.031</td></tr><tr><td align="left" valign="top" charoff="50">706</td><td align="left" valign="top" charoff="50">R</td><td align="char" valign="top" char="." charoff="50">1.000</td></tr><tr><td align="left" valign="top" charoff="50">707</td><td align="left" valign="top" charoff="50">R</td><td align="char" valign="top" char="." charoff="50">0.995</td></tr></tbody></table><table-wrap-foot><fn id="t3-fn1"><p>Abbreviations: A1AT, alpha-1-antitrypsin; BNF, brain-derived neurotrophic factor; EGF, epidermal growth factor; MADRS, montgomery-asberg depression scale; MPO, myeloperoxidase; NR, non-responder; PR, partial responder; R, responder; TNFR2, tumor necrosis factor receptor type 2. Indicates the individual patient identifier, and the response group designation (R, PR and NR) and the predicted probability of response based upon analysis of baseline biomarker data. We used partial least squares discriminant analysis to choose the important variables (BDNF, EGF, MPO, TNFR2 and A1AT) in predicting response. One possible outlier (*) was patient 608 who was designated a partial responder based on a single MADRS score of 16 which indicated a change from moderate to mild depression. The observed probability was consistent with the patient being a NR.</p></fn></table-wrap-foot></table-wrap></floats-group></article>